Alexandria, Va. The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Consumer
Healthcare today announced the 2008 winners of the annual IADR/GSK Innovation in Oral Care Awards. The three
prestigious awards recognize research in innovative oral care technologies that may maintain and improve oral health and the
quality of life.
Sharing the $225,000 unrestricted research grant, which is funded by GSK Consumer Healthcare and administered by the
- Urban Hagg, D.D.S., The Prince Philip Dental Hospital, University of Hong Kong, China, and co-investigators Ricky
Wong, Lakshman Samaranayake, Richard Kao, and Michelle Yuen for A Natural Edible Agent for Reduction of Oral
Biofilm. This research study will look at Prunus mume, a common fruit in Asia, and its effectiveness in inhibiting
bacteria commonly found in oral biofilm. If shown to be effective, Prunus mume will be accepted as a natural oral
biofilm-reducing agent, which would ultimately help in the prevention of dental caries and periodontal disease.
- Keith Kirkwood, D.D.S., Ph.D., Microbiology and Immunology, Medical University of South Carolina, for
Targeting Post-transcriptional Signaling for Periodontitis. This research study will explore the role of posttranscriptional
cytokine regulation in periodontal inflammation and bone loss, which may yield new possibilities for
the treatment of periodontal diseases and other chronic inflammatory diseases.
- David T.W. Wong, D.M.D., D.M.Sc., University of California at Los Angeles (UCLA), School of Dentistry, and coinvestigators
Wei Lao and Fang Wei for SPITDX: A Universal Platform for Salivary Biomarker Detection. This
research project aims to develop a universal platform, where salivary biomarkers associated with disease phenotypes
can be rapidly detected in under five minutes. This platform will allow scientific results to be transferred faster,
allowing patients who suffer from oral and systemic diseases to be notified sooner and receive the most informative
This year, the IADR/GSK Innovation in Oral Care Awards received 35 applications from teams of researchers from around
the globe. Each application was reviewed by a panel of experts under the chairmanship of Dr. Mariano Sanz, Dean,
Universidad Complutense de Madrid Dental School.
The awards will be presented during the 86th General Session & Exhibition of the IADR, to be held July 2-5, 2008, in
Toronto, Ontario, Canada.
GlaxoSmithKline is privileged to work with the IADR in providing the Innovation in Oral Care Awards to help such talented
teams of researchers develop new treatments and products, said Dr. David Alexander, Director of Global Dental
Professional Relations for GlaxoSmithKline Consumer Healthcare. The IADR membership comprises some of the most
innovative scientists and clinicians in the field of oral health. All three winning entries address very significant quality-of-life
issues, and GSK hopes that these innovative concepts will one day be widely available as new products to improve the lives of
those suffering from disease.
On behalf of the IADR, I thank GSK and Dr. David Alexander for making possible this unique and prestigious award
program, said IADR President Deborah Greenspan. Under the excellent direction of Dr. Mariano Sanz, the committee
reviewed many outstanding research projects, and we are pleased that the winning projects fit the key criterion for this
award, namely, the potential of the proposed research for translation to publicly available and cost-effective therapies in the
In this the fifth year of these awards, the grant from GSK has supported 13 teams from the United States, Northern Ireland,
Scotland, Hong Kong, Israel and Iceland with over $1 million to further their research. In addition, applications have been
received from over 190 teams of researchers from over 26 countries, all of which have been focused on better oral health
and improved quality of life.
Related medicine news :1
. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence2
. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis3
. GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting4
. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence5
. GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding6
. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties7
. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program8
. AUDIO from Medialink and GlaxoSmithKline: Get Ready to Get Moving to a New You in the New Year9
. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight10
. VIDEO from Medialink and GlaxoSmithKline: Really Think You Can Lose 30 Pounds in 30 Days?11
. AUDIO from Medialink and GlaxoSmithKline: Setting Realistic Goals for a New You in the New Year